tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TAK Stock Latest News

Takeda Issues $500M Senior Note Due 2034
Company AnnouncementsTakeda Issues $500M Senior Note Due 2034
2d ago
6K
TAK
Takeda Shareholders Approve Dividends and Directors
PremiumCompany Announcements
Takeda Shareholders Approve Dividends and Directors
5d ago
6K
TAK
Codexis enters asset purchase agreement with Crosswalk Therapeutics
PremiumThe Fly
Codexis enters asset purchase agreement with Crosswalk Therapeutics
5d ago
TAK
CDXS
Takeda Advances Sustainable Pharma Innovation
PremiumCompany Announcements
Takeda Advances Sustainable Pharma Innovation
6d ago
6K
TAK
Takeda: Japanese MHLW approves LIVTENCITY
PremiumThe Fly
Takeda: Japanese MHLW approves LIVTENCITY
13d ago
TAK
Takeda receives approval from European Commission for FRUZAQLA
PremiumThe FlyTakeda receives approval from European Commission for FRUZAQLA
15d ago
TAK
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
TAK
ARDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
17d ago
TAK
AVTE
Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls
19d ago
KR
GSK
Ovid Therapeutics price target lowered to $3 from $9 at B. Riley
PremiumThe Fly
Ovid Therapeutics price target lowered to $3 from $9 at B. Riley
19d ago
TAK
OVID
Takeda presents long-term data from Phase 3 ADVANCE-CIDP 3 trial of HYQVIA
PremiumThe Fly
Takeda presents long-term data from Phase 3 ADVANCE-CIDP 3 trial of HYQVIA
19d ago
TAK
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
PremiumThe Fly
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
19d ago
TAK
OVID
Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg
PremiumThe FlyOvid Therapeutics price target lowered to $2 from $7 at Ladenburg
19d ago
TAK
OVID
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
19d ago
TAK
OVID
Takeda’s Mixed Results in Soticlestat Trials
PremiumCompany Announcements
Takeda’s Mixed Results in Soticlestat Trials
20d ago
6K
TAK
Ovid Therapeutics notes Takeda’s announcement on Phase 3 results of soticlestat
PremiumThe Fly
Ovid Therapeutics notes Takeda’s announcement on Phase 3 results of soticlestat
20d ago
TAK
OVID
Takeda says SKYLINE, SKYWAY studies of soticlestat miss primary endpoints
PremiumThe Fly
Takeda says SKYLINE, SKYWAY studies of soticlestat miss primary endpoints
20d ago
TAK
Takeda enters exclusive license agreement for olverembatinib with Ascentage
PremiumThe Fly
Takeda enters exclusive license agreement for olverembatinib with Ascentage
23d ago
TAK
Takeda expands collaboration with PIH to extend MA community health initiatives
PremiumThe Fly
Takeda expands collaboration with PIH to extend MA community health initiatives
26d ago
TAK
Takeda Pharmaceutical Unveils Employee Incentive Plan
PremiumCompany AnnouncementsTakeda Pharmaceutical Unveils Employee Incentive Plan
26d ago
6K
TAK
Takeda Corrects Shareholder Meeting Notice
PremiumCompany Announcements
Takeda Corrects Shareholder Meeting Notice
27d ago
6K
TAK
Takeda Prices Bonds to Refinance Debt
PremiumCompany Announcements
Takeda Prices Bonds to Refinance Debt
30d ago
6K
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >